Market Tracker

06/24 5:16pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

30.00
Delayed Data
As of Jun 24
 -0.76 / -2.47%
Today’s Change
28.82
Today|||52-Week Range
46.24
-30.49%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close30.76
Today’s open29.84
Day’s range28.82 - 30.62
Volume889,510
Average volume (3 months)897,468
Market cap$2.1B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-52.00%
Earnings growth (this year)+13.41%
Earnings growth (next 5 years)+14.05%
Revenue growth (last year)-7.08%
P/E ratio20.2
Price/Sales3.50
Price/Book3.12

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...-1.07-3.53%
GLPGGalapagos NV-2.93-5.42%
TSROTESARO Inc-1.95-4.32%
RAREUltragenyx Pharmaceu...-2.78-5.35%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)$0.37
Annual revenue (last year)$723.1M
Annual profit (last year)$80.2M
Net profit margin11.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts